Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2VD8

The crystal structure of alanine racemase from Bacillus anthracis (BA0252)

Summary for 2VD8
Entry DOI10.2210/pdb2vd8/pdb
Related2VD9
DescriptorALANINE RACEMASE, PYRIDOXAL-5'-PHOSPHATE, MAGNESIUM ION, ... (5 entities in total)
Functional Keywordspyridoxal 5'-phosphate, peptidoglycan synthesis, plp, oppf, l-alanine, isomerase, d- alanine, pyridoxal phosphate, structural genomics, alanine racemase, spore germination, oxford protein production facility, structural proteomics in europe (spine)
Biological sourceBACILLUS ANTHRACIS
Total number of polymer chains2
Total formula weight89399.72
Authors
Primary citationAu, K.,Ren, J.,Walter, T.S.,Harlos, K.,Nettleship, J.E.,Owens, R.J.,Stuart, D.I.,Esnouf, R.M.
Structures of an Alanine Racemase from Bacillus Anthracis (Ba0252) in the Presence and Absence of (R)-1-Aminoethylphosphonic Acid (L-Ala-P).
Acta Crystallogr.,Sect.F, 64:327-, 2008
Cited by
PubMed Abstract: Bacillus anthracis, the causative agent of anthrax, has been targeted by the Oxford Protein Production Facility to validate high-throughput protocols within the Structural Proteomics in Europe project. As part of this work, the structures of an alanine racemase (BA0252) in the presence and absence of the inhibitor (R)-1-aminoethylphosphonic acid (L-Ala-P) have determined by X-ray crystallography to resolutions of 2.1 and 1.47 A, respectively. Difficulties in crystallizing this protein were overcome by the use of reductive methylation. Alanine racemase has attracted much interest as a possible target for anti-anthrax drugs: not only is D-alanine a vital component of the bacterial cell wall, but recent studies also indicate that alanine racemase, which is accessible in the exosporium, plays a key role in inhibition of germination in B. anthracis. These structures confirm the binding mode of L-Ala-P but suggest an unexpected mechanism of inhibition of alanine racemase by this compound and could provide a basis for the design of improved alanine racemase inhibitors with potential as anti-anthrax therapies.
PubMed: 18453697
DOI: 10.1107/S1744309108007252
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.47 Å)
Structure validation

227111

数据于2024-11-06公开中

PDB statisticsPDBj update infoContact PDBjnumon